The Role of Long Non-Coding RNAs in Thyroid Cancer
Thyroid cancer, the most common endocrine malignancy, has become the most commonly diagnosed malignant solid tumor. Moreover, some cases have poor prognosis, and the survival period is only 3–5 months. Long noncoding RNAs (lncRNAs) are a group of functional RNA molecules more than 200 nucleotides in...
Main Authors: | Xuejiao Peng, Kun Zhang, Li Ma, Junfeng Xu, Weiqin Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00941/full |
Similar Items
-
Long non-coding RNAs and endometrial cancer
by: Hongyang Liu, et al.
Published: (2019-11-01) -
Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications
by: Lei Zhang, et al.
Published: (2019-05-01) -
Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star
by: Tao Xu, et al.
Published: (2018-07-01) -
Long Non-Coding RNAs in Multiple Myeloma
by: Romana Butova, et al.
Published: (2019-01-01) -
Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis
by: Honglai Zhang, et al.
Published: (2019-01-01)